The nation of Zimbabwe has declined a significant American health deal worth $367m (272 million pounds) spanning five years over the United States' demand for confidential biological samples.
This rejection came to light following a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".
An official representative has since clarified that the US was demanding access to health data for scientific study and commercial gain while refused to share the resulting advantages from any future treatments.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had provided more than $1.9bn for health programmes to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for more talks to find a deal suitable to all parties so the country's vital HIV programme can continue.
Wider Background
This development comes after a comparable situation in Kenya, where a court blocked a related deal with the US after concerns were filed about the security of citizens' health data.
After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and closed the US Agency for International Development (USAID).
The agency had overseen assistance for the US government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government deals to boost openness and accountability.
Based on reports, Sixteen African countries have to date signed these new health pacts, constituting over $18.3bn in committed funds.
Details of the Rejected Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"Our nation was requested to surrender its biological resources and data for a long time, without any equivalent guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.
"Put simply, our nation would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be available to our people should a new health crisis arise."
National Interest and International Frameworks
He also said that the American exit from the World Health Organization (WHO) and its push of one-on-one health agreements were upending frameworks previously set up through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing system created to manage potential pandemics.
"This mechanism is intended to ensure that when a country provides its information, the benefits – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the resources to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We encourage continued dialogue with our American counterparts on how subsequent co-operation could be structured in a manner that respects the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but suggested that negotiations need to persist since a large portion of the nation's Aids initiatives depended on international support.
"If technical issues exist, such as those involving data governance or agreement terms, these can frequently be resolved via detailed discussion and mutually agreed protections," the group added.
The halted deal highlights the complex debate between accepting crucial international aid and safeguarding a country's data in an ever more data-driven world.